(Q33943443)

30 July 2017

1 reference

title

The role of costimulation in autoimmune demyelination (English)

1 reference

30 July 2017

Racke MK

1

1 reference

30 July 2017

Ratts RB

2

1 reference

30 July 2017

Arredondo L

3

1 reference

30 July 2017

Perrin PJ

4

1 reference

30 July 2017

Lovett-Racke A

5

1 reference

30 July 2017

publication date

1 July 2000

1 reference

Journal of Neuroimmunology

30 July 2017

published in

1 reference

30 July 2017

volume

107

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

205-215

1 reference

T cells responsive to myelin basic protein in patients with multiple sclerosis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Revised estimate of the prevalence of multiple sclerosis in the united states

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Relevance of experimental allergic encephalomyelitis to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Functional expression of B7/BB1 on activated T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

The two-signal model of lymphocyte activation twenty-one years later

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Myelin basic protein administration in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

1 reference

7 January 2021

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Amelioration of Autoimmune Encephalomyelitis by Myelin Basic Protein Synthetic Peptide-Induced Anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Late complications of immune deviation therapy in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Failure of basic protein therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Absence of B7-dependent responses in CD28-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Molecules involved in T-cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

The B7 and CD28 receptor families

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

CD28 activation promotes Th2 subset differentiation by human CD4+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Fas and Fas ligand: lpr and gld mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Intravenous antigen administration as a therapy for autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Receptor-stimulated death pathway is opened by antigen in mature T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Epidemiology of multiple sclerosis: a critical overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Activation and differentiation requirements of primary T cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Critique of experimental trials of therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Treatment of chronic relapsing experimental allergic encephalomyelitis with the intravenous administration of splenocytes coupled to encephalitogenic peptide 91-103 of myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Loss rather than downregulation of CD4+ T cells as a mechanism for remission from experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900230-7

7 January 2021

10.1016/S0165-5728(00)00230-7

Identifiers

DOI

1 reference

30 July 2017

1 reference